Pharmafile Logo

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

- PMLiVE

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For the >7,000 distinct rare conditions, around 70% of which begin in childhood, many patients and families face common challenges including delayed diagnosis, fragmented care, and significant social and financial burdens. A recent World Economic Forum white paper, “Making Rare Diseases Count: How Better Data Can Unlock a Multi‑Trillion‑Dollar Opportunity,” argues that these conditions represent not only a profound human challenge, but also one of the largest untapped opportunities in global health and economic resilience.

Access the whitepaper here

The paper highlights the massive but largely invisible cost of rare diseases, estimated at between USD 7.2 and 8.6 trillion each year, and calls for stronger data systems to make this burden visible and actionable. Its roadmap centres on five priorities: defining a minimum dataset across countries, strengthening patient registries, expanding screening and diagnostic capacity, enabling trusted data sharing, and using AI and digital tools to close evidence gaps.

This agenda builds on growing policy momentum, including the pivotal 2025 World Health Assembly resolution on rare diseases, sponsored by Egypt and Spain and co‑sponsored by 39 other UN Member States, which includes a call to member states to support education for healthcare providers on rare diseases. Shortening the diagnostic odyssey through education is crucial: today, only 19% of physicians feel confident diagnosing rare diseases, and many patients wait years for an accurate diagnosis.

Access the whitepaper here

Medscape, as a contributor to the WEF paper, brings evidence that targeted professional education can help close this gap. Its rare disease programmes, informed by global survey data and real‑world outcomes, have shown that clinicians who participate in accredited training as compared with similar cohorts who do not, order significantly more genetic tests and code more often for rare diseases. This suggests that education may help shorten the diagnostic journey in real world practice. Medscape data also reveal striking gaps in physician awareness of rare disease prevalence, with a majority reporting that they never or rarely (defined as 1-2x per year), see rare disease patients despite evidence suggesting they should be seeing several per week.

With a community of >13 million healthcare professionals and the largest dedicated library of rare disease education, Medscape is positioned to translate the WEF’s data‑driven roadmap into everyday clinical practice. By aligning better data with focused education, the rare‑disease community can turn global recognition into earlier diagnoses, better access to care, and measurable value for patients, health systems, and societies worldwide.

To learn more about how Medscape Education is tackling the rare disease burden through precision education, please contact S Christy Rohani‑Montez.

Sign up to Medscape Education’s Rare Disease Newsletter here.

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

World AIDS Day 35: Medscape’s Commitment to the Elimination of HIV through Education and Looking Towards the Future

December 1 marks the 35th year commemorating World AIDS Day, and the theme is “Remember and Commit.” While new infections have steadily declined over the last several years, HIV remains a...

Planting the Seeds for Future Women Leaders in Medicine

What are the qualities needed to be a leader in the medical field of oncology?Of course, you must be a good clinician. But you also have to be wise and...

Unmet Needs and Novel Advances at the 2023 Women’s Health Master Class

On November 8-9, Medscape Education held the 2nd Annual Women’s Health Master Class—Modernizing Women's Health: Elevating Quality Care for Everyday Practice, two days dedicated to bringing the latest advances in...

A Passionate Cause: Elevating Women to Reshape Medicine

“We need more outstanding leaders from underrepresented communities, including women and those from different ethnicities”, says Antonella Chadha Santuccione, co-founder and CEO of the nonprofit Women's Brain Project in Zurich,...

Hear from her: Meet your hosts

Every day, women leaders are changing the healthcare landscape for the better. Our Women in Healthcare Leadership Podcast Series features some of the women working to elevate equity, achieve gender...

Message from the Women in Medicine™ Summit: “Be the Change You Want to See”

What are some of the biggest gaps that women still face in healthcare today?“So many I could talk for hours!” says Shikha Jain, MD, FACP, President, CEO, Founder Women in...

Changing What’s Possible for Women in Healthcare

Career choices are driven by many factors. In medicine, doctors are often drawn to a particular specialty following a personal experience.That’s the case with both of the renowned speakers in...

Honoring Educational Partners at ACG

The recent ACG conference was an opportunity for members of the Medscape team to shine a light on their educational partners and honor them for their exceptional work.On October 21,...